Copyright
©The Author(s) 2022.
World J Clin Cases. Apr 6, 2022; 10(10): 3101-3112
Published online Apr 6, 2022. doi: 10.12998/wjcc.v10.i10.3101
Published online Apr 6, 2022. doi: 10.12998/wjcc.v10.i10.3101
Figure 1 European Organisation for Research and Treatment of Cancer QLQ-CIPN20 questionnaire.
Results are expressed as percent of 100%.
Figure 2 European Organisation for Research and Treatment of Cancer QLQ-CR29 questionnaire.
Results are expressed as percent of 100%.
Figure 3 Disease-free survival in stage III colon cancer patients that underwent 6 mo of chemotherapy vs patients that discontinued chemotherapy.
- Citation: Prutianu I, Alexa-Stratulat T, Cristea EO, Nicolau A, Moisuc DC, Covrig AA, Ivanov K, Croitoru AE, Miron MI, Dinu MI, Ivanov AV, Marinca MV, Radu I, Gafton B. Oxaliplatin-induced neuropathy and colo-rectal cancer patient’s quality of life: Practical lessons from a prospective cross-sectional, real-world study. World J Clin Cases 2022; 10(10): 3101-3112
- URL: https://www.wjgnet.com/2307-8960/full/v10/i10/3101.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i10.3101